Discover how transitioning to iPSC-based allogeneic cell therapies can revolutionize modern healthcare.
Join Jonas Mortensen, Cellistic's Chief Commercial Officer, as he guides you through the evolving landscape of cell therapy.
You'll also hear from our experts:
• Suzanne Snellenberg – VP cell line Development
• Anne-Sophie Lebrun – MSAT Director
They’ll provide an in-depth look at your product journey:
• Pulse Platform: For developing your iPSC cell line
• Echo Platform: For differentiating into functional NK cells
We will illustrate how these platforms work together to shape your unique cell therapy journey. Following the webinar, we will host an interactive Q&A session.
You can view this webinar from your computer, tablet or mobile phone.
You'll also hear from our experts:
• Suzanne Snellenberg – VP cell line Development
• Anne-Sophie Lebrun – MSAT Director
They’ll provide an in-depth look at your product journey:
• Pulse Platform: For developing your iPSC cell line
• Echo Platform: For differentiating into functional NK cells
We will illustrate how these platforms work together to shape your unique cell therapy journey. Following the webinar, we will host an interactive Q&A session.
You can view this webinar from your computer, tablet or mobile phone.
